Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study
Diabetes, Obesity and Metabolism · 16.11.2026
DOI: 10.1111/dom.71548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 16.11.2026. Verfasst von E Gökce und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Postprandial reactive hypoglycaemia syndrome (PRHS) is an increasingly recognized complication after Roux‐en‐Y gastric bypass (RYGB) surgery. We investigated whether endoscopic ultrasound (EUS)‐guided bypass reversal could provide a minimally invasive alternative to surgery in patients with severe, therapy‐refractory PRHS.
Methods
We conducted a prospective pilot study in 12 patients with severe, therapy‐refractory PRHS after RYGB. A 20 × 10 mm lumen‐apposing metal stent (LAMS) was placed between the gastric pouch and excluded stomach. Patients were followed for 6 months with four visits and a mixed‐meal test at 6 months. Primary outcomes were immediate and sustained clinical response. Secondary outcomes included technical success, quality of life assessed using a visual analogue scale (VAS), adverse events and weight change.
Results
Technical success was achieved in all patients. Immediate clinical response occurred in 10/12 patients (83.3%). Sustained response was observed in 7/10 patients with 6‐month follow‐up (70.0%; 7/8 responders). At 6 months, median VAS increased by 5.0 points (97.85% CI: 0.0–8.0) in all patients and by 6.0 points (99.22% CI: 2.0–8.0) in responders. Adverse events occurred in 2/10 patients and were moderate. One patient developed gastric discomfort and reflux; another experienced stent migration with loss of response, restored after endoscopic repositioning and fixation. Mean weight change at 6 months was −0.3 kg (95% CI: −3.89 to 3.29).
Conclusion
In this prospective pilot study, EUS‐guided gastric bypass reversal was feasible, appeared safe and was associated with a promising clinical response in severe, therapy‐refractory PRHS after RYGB. Larger studies are needed to confirm these preliminary findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium.
- Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium.
- Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.
- Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium.
ORCID-Profile: E Gökce, Y Van Nieuwenhove, B Lapauw, C Verroken, P Hindryckx
Zitieren
APA
Gökce, E., De Muyt, E., Van Nieuwenhove, Y., Lapauw, B., Verroken, C., & Hindryckx, P. (2026). Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71548
Vancouver
Gökce E, De Muyt E, Van Nieuwenhove Y, Lapauw B, Verroken C, Hindryckx P. Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71548
BibTeX
@article{Gkce2026,
author = {Gökce, E and De Muyt, E and Van Nieuwenhove, Y and Lapauw, B and Verroken, C and Hindryckx, P},
title = {Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71548}
}
EUVIMED